Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM

Louis, 2007, The 2007 WHO classification of tumours of the central nervous system, Acta Neuropathol, 114, 97, 10.1007/s00401-007-0243-4 Holland, 2000, Glioblastoma multiforme: the terminator, Proc Natl Acad Sci U S A, 97, 6242, 10.1073/pnas.97.12.6242 Stupp, 2005, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma, N Engl J Med, 352, 987, 10.1056/NEJMoa043330 Bissell, 2011, Why don't we get more cancer? a proposed role of the microenvironment in restraining cancer progression, Nat Med, 17, 320, 10.1038/nm.2328 Hutmacher, 2010, Biomaterials offer cancer research the third dimension, Nat Mater, 9, 90, 10.1038/nmat2619 Hutmacher, 2010, Can tissue engineering concepts advance tumor biology research?, Trends Biotechnol, 28, 125, 10.1016/j.tibtech.2009.12.001 Kimlin, 2013, In vitro three-dimensional (3D) models in cancer research: an update, Mol Carcinog, 52, 167, 10.1002/mc.21844 Benton, 2009, Advancing science and technology via 3D culture on basement membrane matrix, J Cell Physiol, 221, 18, 10.1002/jcp.21832 Benton, 2011, Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells, Int J Cancer, 128, 1751, 10.1002/ijc.25781 Feder-Mengus, 2008, New dimensions in tumor immunology: what does 3D culture reveal?, Trends Mol Med, 14, 333, 10.1016/j.molmed.2008.06.001 Fischbach, 2007, Engineering tumors with 3D scaffolds, Nat Methods, 4, 855, 10.1038/nmeth1085 Fischbach, 2009, Cancer cell angiogenic capability is regulated by 3D culture and integrin engagement, Proc Natl Acad Sci U S A, 106, 399, 10.1073/pnas.0808932106 Hirschhaeuser, 2010, Multicellular tumor spheroids: an underestimated tool is catching up again, J Biotechnol, 148, 3, 10.1016/j.jbiotec.2010.01.012 Kievit, 2010, Chitosan-alginate 3D scaffolds as a mimic of the glioma tumor microenvironment, Biomaterials, 31, 5903, 10.1016/j.biomaterials.2010.03.062 Kleinman, 2005, Matrigel: basement membrane matrix with biological activity, Semin Cancer Biol, 15, 378, 10.1016/j.semcancer.2005.05.004 Scott, 1992, Supramolecular organization of extracellular matrix glycosaminoglycans, in vitro and in the tissues, FASEB J, 6, 2639, 10.1096/fasebj.6.9.1612287 Toole, 2004, Hyaluronan: from extracellular glue to pericellular cue, Nat Rev Cancer, 4, 528, 10.1038/nrc1391 Rinaudo, 2008, Main properties and current applications of some polysaccharides as biomaterials, Polym Int, 57, 397, 10.1002/pi.2378 Muzzarelli, 2011, Chitosan composites with inorganics, morphogenetic proteins and stem cells, for bone regeneration, Carbohydr Polym, 83, 1433, 10.1016/j.carbpol.2010.10.044 Schanté, 2011, Chemical modifications of hyaluronic acid for the synthesis of derivatives for a broad range of biomedical applications, Carbohydr Polym, 85, 469, 10.1016/j.carbpol.2011.03.019 Sironen, 2011, Hyaluronan in human malignancies, Exp Cell Res, 317, 383, 10.1016/j.yexcr.2010.11.017 Toole, 2009, Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities, Clin Cancer Res, 15, 7462, 10.1158/1078-0432.CCR-09-0479 Veiseh, 2011, Hyaluronan metabolism in remodeling extracellular matrix: probes for imaging and therapy of breast cancer, Integr Biol, 3, 304, 10.1039/c0ib00096e Naor, 2008, Involvement of CD44, a molecule with a thousand faces, in cancer dissemination, Semin Cancer Biol, 18, 260, 10.1016/j.semcancer.2008.03.015 Wang, 2012, Hyaluronic acid-based scaffold for central neural tissue engineering, Interface Focus, 2, 278, 10.1098/rsfs.2012.0016 Berger, 2004, Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications, Eur J Pharm Biopharm, 57, 35, 10.1016/S0939-6411(03)00160-7 Rinaudo, 2007, Properties and degradation of selected polysaccharides: hyaluronan and chitosan, Corros Eng Sci Technol, 42, 324, 10.1179/174327807X238945 Tan, 2009, Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for cartilage tissue engineering, Biomaterials, 30, 2499, 10.1016/j.biomaterials.2008.12.080 Tan, 2010, Injectable in situ forming biodegradable chitosan-hyaluronic acid based hydrogels for adipose tissue regeneration, Organogenesis, 6, 173, 10.4161/org.6.3.12037 Coimbra, 2011, Sodium hyaluronate/chitosan polyelectrolyte complex scaffolds for dental pulp regeneration: synthesis and characterization, Int J Biol Macromol, 49, 573, 10.1016/j.ijbiomac.2011.06.011 Correia, 2011, Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering, Tissue Eng Part C Methods, 17, 717, 10.1089/ten.tec.2010.0467 Campbell, 2011, A multifunctional 3D co-culture system for studies of mammary tissue morphogenesis and stem cell biology, PLoS One, 6, e25661, 10.1371/journal.pone.0025661 Leung, 2010, Chitosan-alginate scaffold culture system for hepatocellular carcinoma increases malignancy and drug resistance, Pharm Res, 27, 1939, 10.1007/s11095-010-0198-3 Florczyk, 2012, 3D porous chitosan-alginate scaffolds: a new matrix for studying prostate cancer cell-lymphocyte interactions in vitro, Adv Healthc Mater, 1, 590, 10.1002/adhm.201100054 Edmondson, 2009, Design and evaluation of a nano-scale differential tensile test device for nanofibers, Appl Phys Lett, 94, 103101, 10.1063/1.3095439 Miller, 2009, Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method, Glia, 57, 875, 10.1002/glia.20813 Pettikiriarachchi, 2010, Biomaterials for brain tissue engineering, Aust J Chem, 63, 1143, 10.1071/CH10159 Gilbert, 2010, Substrate elasticity regulates skeletal muscle stem cell self-renewal in culture, Science, 329, 1078, 10.1126/science.1191035 Ananthanarayanan, 2011, Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform, Biomaterials, 32, 7913, 10.1016/j.biomaterials.2011.07.005 Merzak, 1994, CD44 mediates human glioma cell adhesion and invasion in vitro, Cancer Res, 54, 3988 Anido, 2010, TGF-beta receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma, Cancer Cell, 18, 655, 10.1016/j.ccr.2010.10.023 Stiles, 2008, Glioma stem cells: a midterm exam, Neuron, 58, 832, 10.1016/j.neuron.2008.05.031 Reynolds, 1992, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science, 255, 1707, 10.1126/science.1553558 Salmaggi, 2006, Glioblastoma-derived tumorospheres identify a population of tumor stem-like cells with angiogenic potential and enhanced multidrug resistance phenotype, Glia, 54, 850, 10.1002/glia.20414 Strojnik, 2007, Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival, Surg Neurol, 68, 133, 10.1016/j.surneu.2006.10.050 Wan, 2011, Association of stem cell-related markers and survival in astrocytic gliomas, Biomarkers, 16, 136, 10.3109/1354750X.2010.536256 Okano, 2002, Musashi: a translational regulator of cell fate, J Cell Sci, 115, 1355, 10.1242/jcs.115.7.1355 Toda, 2001, Expression of the neural RNA-binding protein musashi1 in human gliomas, Glia, 34, 1, 10.1002/glia.1034 Gürsel, 2011, Glioblastoma stem-like cells—biology and therapeutic implications, Cancers, 3, 2655, 10.3390/cancers3022655 Zhang, 2006, Differentiation profile of brain tumor stem cells: a comparative study with neural stem cells, Cell Res, 16, 909, 10.1038/sj.cr.7310104 Kaur, 2005, Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis, Neuro Oncol, 7, 134, 10.1215/S1152851704001115 Bar, 2011, Glioblastoma, cancer stem cells and hypoxia, Brain Pathol, 21, 119, 10.1111/j.1750-3639.2010.00460.x Zagzag, 2000, Expression of hypoxia-inducible factor 1 alpha in brain tumors - association with angiogenesis, invasion, and progression, Cancer, 88, 2606, 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W Li, 2009, Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells, Cancer Cell, 15, 501, 10.1016/j.ccr.2009.03.018 Soeda, 2009, Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1 alpha, Oncogene, 28, 3949, 10.1038/onc.2009.252 Kim, 2011, The role of the 3D environment in hypoxia-induced drug and apoptosis resistance, Anticancer Res, 31, 3237 Bar, 2010, Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres, Am J Pathol, 177, 1491, 10.2353/ajpath.2010.091021 Lakka, 2002, Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion, Oncogene, 21, 8011, 10.1038/sj.onc.1205894 Deryugina, 1997, Matrix metalloproteinase-2 activation modulates glioma cell migration, J Cell Sci, 110, 2473, 10.1242/jcs.110.19.2473 Mikheeva, 2010, TWIST1 promotes invasion through mesenchymal change in human glioblastoma, Mol Cancer, 9, 10.1186/1476-4598-9-194 Elias, 2005, TWIST is expressed in human gliomas and promotes invasion, Neoplasia, 7, 824, 10.1593/neo.04352 Pistollato, 2010, Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma, Stem Cells, 28, 851, 10.1002/stem.415 Bleau, 2009, The ABCG2 resistance network of glioblastoma, Cell Cycle, 8, 2937, 10.4161/cc.8.18.9504 Martin, 2013, Melatonin-induced methylation of the ABCG2/BCRP promoter as a novel mechanism to overcome multidrug resistance in brain tumour stem cells, Br J Cancer, 108, 2005, 10.1038/bjc.2013.188 Chua, 2008, Characterization of a side population of astrocytoma cells in response to temozolomide, J Neurosurg, 109, 856, 10.3171/JNS/2008/109/11/0856 Dean, 2005, Tumour stem cells and drug resistance, Nat Rev Cancer, 5, 275, 10.1038/nrc1590